人YAP1基因亚型的质粒构建及表达鉴定

摘要
图/表
参考文献
相关文章 (4)

全文: PDF (1501 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的：构建人Yes相关蛋白1（YAP1）基因亚型1δ、2δ的真核表达载体并进行瞬时表达鉴定，为研究YAP1亚型间的区别及其在肿瘤中的作用打下基础。方法：在已有pCI2-Flag-YAP1-2γ质粒的基础上，利用重叠PCR增加碱基的方法得到YAP1-2δ的片段，再同理删减WW基因序列得到YAP1-1δ片段，通过Cla I和Sal I两个酶切位点将片段和pCI2载体相连接，构建pCI2-Flag-YAP1-1δ及pCI2-Flag-YAP1-2δ质粒。利用测序确认完整的DNA序列。在HEK293细胞中瞬时转染质粒，用Western blot方法检测YAP1两个亚型的蛋白表达。结果：重组质粒经双酶切和基因测序比对鉴定正确，HEK293细胞经瞬时转染表达出YAP1-1δ和YAP1-2δ蛋白。结论：成功构建了pCI2-Flag-YAP1-1δ及pCI2-Flag-YAP1-2δ真核表达质粒，并在HEK293细胞内过表达成功。为进一步探讨YAP1各亚型对肿瘤发展的影响奠定基础。

	服务
	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	董晶莱
	张金三
	郭强
	陈千杰
	郭丽莎
	李校堃

关键词 ： YAP1基因, 重叠PCR, 真核表达, 重组质粒, HEK293细胞

Abstract：Objective: To construct two isoforms of YAP1 for further research into their difference. Methods: YAP1-1δ and YAP1-2δ fragments were obtained by using overlapping PCR. And then the two DNA fragments were respectively ligated to the plasmid contained partial YAP1 gene via ClaI and SalI two restriction enzyme cutting sites. The recombinant vectors named pCI2-Flag-YAP1-1δ and pCI2-Flag-YAP1-2δ were identified by restriction enzyme digestion and gene sequencing. After transfection of 293 cells with the two vectors for 48 h, the expression of YAP1 protein was detected by Western blot. Results: The two over-expressing plasmids were successfully constructed and YAP1-1δ and YAP1-2δ proteins were strongly expressed in HEK293 cells. Conclusion:
The HEK293 cells could transiently express YAP1-1δ and YAP1-2δ by using the recombinant plasmids pCI2-Flag-YAP1-1δ and pCI2-Flag-YAP1-2δ, which lays a foundation for further study of the different isoforms of YAP1 and its mechanism in the development of tumorigenesis.

Key words： YAP1 gene overlapping PCR eukaryotic expression recombinant vector HEK293 cells

收稿日期: 2017-12-04

基金资助:国家自然科学基金青年基金资助项目（81702912）

通讯作者: 李校堃，教授，Email：xiaokunli@wmu.edu.cn。

作者简介: 董晶莱（1992-），女，浙江温州人，硕士生。

链接本文:

https://xb.wmu.edu.cn/CN/ 或 https://xb.wmu.edu.cn/CN/Y2018/V48/I4/241

[1] SANDESC M, DINU A, ROGOBETE A F, et al. Circulating microRNAs expressions as genetic biomarkers in pancreatic cancer patients continuous non-invasive monitoring[J]. Clin Lab, 2017, 63(10): 1561-1566.
[2] CHEN Y, SHI Y, YAN H, et al. Timing of chemotherapy-induced neutropenia: the prognostic factor in advanced pancreatic cancer patients treated with gemcitabine/gemcitabine-based chemotherapy[J]. Oncotarget, 2017, 8(39): 66593-66600.
[3] ZHANG W, NANDAKUMAR N, SHI Y, et al. Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocar-cinoma[J]. Sci Signal, 2014, 7(324): ra42.
[4] NGUYEN L T, TRETIAKOVA M S, SILVIS M R, et al. ERG activates the YAP1 transcriptional program and induces the development of age-related prostate tumors[J]. Cancer Cell, 2015, 27(6): 797-808.
[5] MELFI S, COLCIAGO A, GIANNOTTI G, et al. Stressing out the Hippo/YAP signaling pathway: toward a new role in Schwann cells[J]. Cell Death Dis, 2015, 6: e1915.
[6] CAO X, PFAFF S L, GAGE F H. YAP regulates neural progenitor cell number via the TEA domain transcription factor [J]. Genes Dev, 2008, 22(23): 3320-3334.
[7] PLOUFFE S W, HONG A W, GUAN K L. Disease implications of the Hippo/YAP pathway[J]. Trends Mol Med, 2015, 21(4): 212-222.
[8] SUDOL M. YAP1 oncogene and its eight isoforms[J]. Oncogene, 2013, 32(33): 3922.
[9] SUDOL M. Newcomers to the WW domain-mediated network of the hippo tumor suppressor pathway[J]. Genes Cancer, 2010, 1(11): 1115-1118.
[10] 丁鑫, 孟刚, 童晓玲, 等. WW结构域与Hippo信号通路[J]. 蚕业科学, 2013, 39(6): 1177-1185.
[11] 李敏睿, 张盛洪, 钟碧慧. Hippo信号通路在恶性肿瘤及干细胞中的作用[J]. 胃肠病学和肝病学杂志, 2013, 22(4): 389-392.
[12] 邱勤明, 石秋燕, 王江, 等. Hippo信号通路与肿瘤发生的研究进展[J]. 四川生理科学杂志, 2016, 38(1): 35-38.
[13] HALL C A, WANG R, MIAO J, et al. Hippo pathway effector Yap is an ovarian cancer oncogene[J]. Cancer Res, 2010, 70(21): 8517-8525.
[14] 白帆, 刘小龙, 易俊, 等. Hippo通路与恶性肿瘤侵袭转移的相关性研究进展[J]. 癌症进展, 2016, 14(3): 213-216.
[15] 史梦婕, 邵松军, 李洁媚, 等. Hippo通路与肿瘤相关性研究进展[J]. 中国细胞生物学学报, 2014, 36(3): 361-365.
[16] 吴卉, 花荣, 陈锦先. Hippo通路及靶因子YAP与肿瘤关系的研究进展[J]. 实用医学杂志, 2013, 29(4): 515-517.
[17] 周广玺, 张翠萍, 魏文超, 等. 慢性胃炎及微环境与胃癌[J]. 齐鲁医学杂志, 2014, 29(2): 177-180.
[18] 王杰, 喻超, 周显飞, 等. MiRNA-138-5p抑制人胰腺癌细胞增殖能力[J]. 世界华人消化杂志, 2016, 24(28): 3970-3977.
[19] 周青峰, 罗慧, 朱雪琼. Yes相关蛋白在妇科恶性肿瘤中的研究进展[J]. 温州医科大学学报, 2016, 46(7): 543-547.
[20] PAN D. The hippo signaling pathway in development and cancer[J]. Dev Cell, 2010, 19(4): 491-505.
[21] LEUNG C Y, ZERNICKA-GOETZ M. Angiomotin prevents pluripotent lineage differentiation in mouse embryos via Hippo pathway-dependent and -independent mechanisms[J]. Nat Commun, 2013, 4: 2251.
[22] ARAGóN E, GOERNER N, ZAROMYTIDOU A I, et al. A Smad action turnover switch operated by WW domain readers of a phosphoserine code[J]. Genes Dev, 2011, 25(12): 1275-1288.
[23] LEHMANN W, MOSSMANN D, KLEEMANN J, et al. ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types[J]. Nat Commun, 2016, 7: 10498.